Literature DB >> 18223330

Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.

Ankur R Sangoi1, Robert A Soslow, Nelson N Teng, Teri A Longacre.   

Abstract

The differential diagnostic problems usually associated with clear cell carcinoma (CCC) of the ovary have been well characterized and include primitive germ cell tumor, sex cord stromal tumor, and metastasis. Distinction from other types of surface epithelial carcinoma may also pose a diagnostic challenge, but the potential for misdiagnosis of serous tumor of low malignant potential (S-LMP) is not well recognized. We report 13 cases of ovarian CCC with prominent papillary architecture that were initially misdiagnosed as S-LMP or low-grade serous carcinoma either on frozen section or at final diagnosis. The ages of the patients ranged from 39 to 65 years (mean, 52.2 y). All patients presented with a pelvic mass; 1 was undergoing evaluation for infertility. Macroscopically, most were described as unilateral, multilocular cysts with internal papillary structures. On microscopic examination, each tumor had a papillary architecture that accounted for 30% to 95% of the tumor; in 6 cases, the cores of the papillae were hyalinized. The neoplastic cells covering the papillae had clear to granular and eosinophilic cytoplasm. Hobnail cells were focal and often subtle. Most had a low mitotic index (9/13) and/or deceptively bland cytology (8/13); only careful attention to the cytologic features and/or mitotic index allowed correct identification of the tumor type in 5 cases. Six were associated with pelvic/ovarian endometriosis. Ten were Federation of Gynecology and Obstetrics stage I (8 IA, 2 IC), 2 were stage II (1 IIB, 1 IIC), and 1 stage IIIC. CCC with prominent papillary architecture is uncommon, but may pose a challenging differential diagnosis with S-LMP, resulting in inadequate staging and delayed treatment. Features most helpful in distinguishing papillary CCC are unilaterality, nonhierarchical branching, monomorphous cell population, and the presence of more typical CCC patterns elsewhere in the tumor. The presence of endometriosis, although not specific, should also prompt consideration for papillary CCC. Increased numbers of mitotic figures may not be present and high-grade cytologic atypia may be focal, requiring careful examination of multiple tumor sections for detection. As CCC and S-LMP exhibit significantly different immunoreactivity for Wilms' Tumor 1 and estrogen receptor, these markers may also be useful adjunctive tests in problematic cases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18223330     DOI: 10.1097/PAS.0b013e31814fa9b0

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

1.  Cyclooxygenase-2 promotes ovarian cancer cell migration and cisplatin resistance via regulating epithelial mesenchymal transition.

Authors:  Lin Deng; Ding-Qing Feng; Bin Ling
Journal:  J Zhejiang Univ Sci B       Date:  2020 Apr.       Impact factor: 3.066

2.  Napsin A is a specific marker for ovarian clear cell adenocarcinoma.

Authors:  Yoriko Yamashita; Tetsuro Nagasaka; Aya Naiki-Ito; Shinya Sato; Shugo Suzuki; Shinya Toyokuni; Masafumi Ito; Satoru Takahashi
Journal:  Mod Pathol       Date:  2014-04-11       Impact factor: 7.842

3.  Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.

Authors:  Celeste Leigh Pearce; Claire Templeman; Mary Anne Rossing; Alice Lee; Aimee M Near; Penelope M Webb; Christina M Nagle; Jennifer A Doherty; Kara L Cushing-Haugen; Kristine G Wicklund; Jenny Chang-Claude; Rebecca Hein; Galina Lurie; Lynne R Wilkens; Michael E Carney; Marc T Goodman; Kirsten Moysich; Susanne K Kjaer; Estrid Hogdall; Allan Jensen; Ellen L Goode; Brooke L Fridley; Melissa C Larson; Joellen M Schildkraut; Rachel T Palmieri; Daniel W Cramer; Kathryn L Terry; Allison F Vitonis; Linda J Titus; Argyrios Ziogas; Wendy Brewster; Hoda Anton-Culver; Alexandra Gentry-Maharaj; Susan J Ramus; A Rebecca Anderson; Doerthe Brueggmann; Peter A Fasching; Simon A Gayther; David G Huntsman; Usha Menon; Roberta B Ness; Malcolm C Pike; Harvey Risch; Anna H Wu; Andrew Berchuck
Journal:  Lancet Oncol       Date:  2012-02-22       Impact factor: 41.316

4.  Clear cell carcinoma of the ovary: multi-slice computed tomography findings.

Authors:  Xubin Li; Zhaoxiang Ye
Journal:  World J Surg Oncol       Date:  2015-04-01       Impact factor: 2.754

Review 5.  Immunohistochemical Biomarkers as a Surrogate of Molecular Analysis in Ovarian Carcinomas: A Review of the Literature.

Authors:  Giacomo Santandrea; Simonetta Piana; Riccardo Valli; Magda Zanelli; Elisa Gasparini; Antonio De Leo; Vincenzo Dario Mandato; Andrea Palicelli
Journal:  Diagnostics (Basel)       Date:  2021-01-29

6.  Immunohistochemical Characterization Improves the Reproducibility of the Histological Diagnosis of Ovarian Carcinoma

Authors:  Nabiha Missaoui; Said Salhi; Ahlem Bdioui; Sarra Mestiri; Nihed Abdessayed; Moncef Mokni; Mohamed Tahar Yacoubi
Journal:  Asian Pac J Cancer Prev       Date:  2018-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.